A-1155463 (BCL-XL Inhibitor) 

To Order Contact us: stephen@expresspharmapulse.com

R(-)-Gossypol (Bcl-2 inhibitor)
SIH-223-50MG 50 mg
EUR 763.2
Description: The substance R(-)-Gossypol is a bcl-2 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is dark yellow solid which is soluble to 25 mM in ethanol and in DMSO..

Aurora A Inhibitor I
A4126-10 10 mg
EUR 240
Description: IC50: 3.4 nM.Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A . Aurora kinases are reported to be required for mitosis and to complete cell division.

Aurora A Inhibitor I
A4126-5 5 mg
EUR 164.4
Description: IC50: 3.4 nM.Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A . Aurora kinases are reported to be required for mitosis and to complete cell division.

Aurora A Inhibitor I
A4126-5.1 10 mM (in 1mL DMSO)
EUR 199.2
Description: IC50: 3.4 nM.Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A . Aurora kinases are reported to be required for mitosis and to complete cell division.

Aurora A Inhibitor I
A4126-50 50 mg
EUR 630
Description: IC50: 3.4 nM.Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A . Aurora kinases are reported to be required for mitosis and to complete cell division.

Aurora A Inhibitor I
M75000 5 mg
EUR 1137.06

Brefeldin A (GEF inhibitor)
SIH-225-25MG 25 mg
EUR 346.8
Description: The substance Brefeldin A is a gef inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white crystalline solid which is soluble to 10 mM in ethanol and to 50 mM in DMSO.

Brefeldin A (GEF inhibitor)
SIH-225-5MG 5 mg
EUR 145.2
Description: The substance Brefeldin A is a gef inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white crystalline solid which is soluble to 10 mM in ethanol and to 50 mM in DMSO.

Huperzine A (ACH inhibitor)
SIH-365-1MG 1 mg
EUR 168
Description: The substance Huperzine A is a ach inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is off-white solid which is soluble in DMSO, methanol or ethanol. .

Huperzine A (ACH inhibitor)
SIH-365-5MG 5 mg
EUR 444
Description: The substance Huperzine A is a ach inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is off-white solid which is soluble in DMSO, methanol or ethanol. .

Herbimycin A (Hsp90 inhibitor)
SIH-116A 100 µg
EUR 277.2
Description: The substance Herbimycin A is a hsp90 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is yellow solid which is soluble in DMSO (>25 mg/ml) and ethanol (10 mg/ml).

Herbimycin A (Hsp90 inhibitor)
SIH-116B 1 mg
EUR 1183.2
Description: The substance Herbimycin A is a hsp90 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is yellow solid which is soluble in DMSO (>25 mg/ml) and ethanol (10 mg/ml).

Trichostatin A (HDAC inhibitor)
SIH-254-1MG 1 mg
EUR 247.2
Description: The substance Trichostatin A is a hdac inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is beige solid which is soluble to 10 mM in ethanol and to 50 mM in DMSO.

Trichostatin A (HDAC inhibitor)
SIH-254-5MG 5 mg
EUR 735.6
Description: The substance Trichostatin A is a hdac inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is beige solid which is soluble to 10 mM in ethanol and to 50 mM in DMSO.

CCK-A receptor inhibitor 1
HY-U00387 10mg
EUR 16242

Pepstatin A (Aspartic protease inhibitor)
SIH-533-25MG 25 mg
EUR 319.2
Description: The substance Pepstatin A is a aspartic protease inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off white powder which is soluble in DMSO (5 mg/ml) or ethanol (1 mg/ml).

Pepstatin A (Aspartic protease inhibitor)
SIH-533-5MG 5 mg
EUR 158.4
Description: The substance Pepstatin A is a aspartic protease inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off white powder which is soluble in DMSO (5 mg/ml) or ethanol (1 mg/ml).

DiscoveryPak? HMG Co-A Inhibitor Set
S242-5 each
EUR 516

Ribunuclease Inhibitor / RNase Inhibitor
105-310 2000 u
EUR 91.2

Ribunuclease Inhibitor / RNase Inhibitor
105-350 10000 u
EUR 284.4

Neurite Outgrowth Inhibitor (Nogo A) Antibody
20-abx218403
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

MAPKII Kinase Inhibitor (Hsp25 Kinase Inhibitor)
SIH-120A 1 mg
EUR 214.8
Description: The substance MAPKII Kinase Inhibitor is a hsp25 kinase inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is white solid which is soluble in DMSO or H20.

GST Inhibitor-1 (Cibacron Blue 3G-A, Sodium Salt)
1555R-1000 each
EUR 248.4

Antizyme Inhibitor 1 (Antizyme inhibitor 1) Antibody
abx230450-100ug 100 ug
EUR 577.2

Antizyme Inhibitor 1 (Antizyme Inhibitor 1) Antibody
20-abx111016
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Monoamine Oxidase A (MAO-A) Inhibitor Screening Kit (Fluorometric)
K796-100 each
EUR 770.4

Syk Inhibitor
1983-1 each
EUR 151.2

Syk Inhibitor
1983-5 each
EUR 339.6

ITK inhibitor
A3509-10 10 mg
EUR 927.6
Description: Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways.

ITK inhibitor
A3509-50 50 mg
EUR 2448
Description: Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways.

Lck Inhibitor
A3539-1 1 mg
EUR 184.8
Description: Lck Inhibitor is a small-molecule inhibitor of with IC50 value of 7 nM [1].The lymphocyte specific kinase which expressed in NK cells and T-cells is a member of the Src kinase family.

Lck Inhibitor
A3539-5 5 mg
EUR 266.4
Description: Lck Inhibitor is a small-molecule inhibitor of with IC50 value of 7 nM [1].The lymphocyte specific kinase which expressed in NK cells and T-cells is a member of the Src kinase family.

MEK inhibitor
A3594-10 10 mg
EUR 895.2
Description: A potent MEK inhibitor, Antitumor agent.

MEK inhibitor
A3594-5 5 mg
EUR 656.4
Description: A potent MEK inhibitor, Antitumor agent.

MEK inhibitor
A3594-5.1 10 mM (in 1mL DMSO)
EUR 717.6
Description: A potent MEK inhibitor, Antitumor agent.

CBF? Inhibitor
C3398-10 10 mg
EUR 243.6
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

CBF? Inhibitor
C3398-25 25 mg
EUR 471.6
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

CBF? Inhibitor
C3398-5 5 mg
EUR 157.2
Description: CBF? inhibitor is a small molecule which binds to CBF? and inhibits its association with Runx1 [1].Core binding factors (CBFs) are heterodimeric transcription factors containing a DNA-binding CBF? component (a RUNX protein) and an enhancer of binding, CBF?.

PKR Inhibitor
C4439-10 10 mg
EUR 247.2
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR Inhibitor
C4439-25 25 mg
EUR 477.6
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR Inhibitor
C4439-5 5 mg
EUR 164.4
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

Lck Inhibitor
HY-12072 100mg
EUR 2422.8

MEK inhibitor
HY-12202 5mg
EUR 514.8

DDR Inhibitor
HY-W018931 10mM/1mL
EUR 1197.6

CPA inhibitor
HY-70005 50mg
EUR 1556.4

Plasminogen activator inhibitor 2 type A Antibody
20-abx109400
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Chk2 Inhibitor
1702-1 each
EUR 216

SCD1 Inhibitor
1716-1 each
EUR 261.6

SCD1 Inhibitor
1716-5 each
EUR 692.4

ACC2 Inhibitor
1717-1 each
EUR 261.6

ACC2 Inhibitor
1717-5 each
EUR 823.2

BRAF inhibitor
A3263-10 10 mg
EUR 459.6
Description: BRAF inhibitor is a potent BRAF inhibitor.

BRAF inhibitor
A3263-5.1 10 mM (in 1mL DMSO)
EUR 537.6
Description: BRAF inhibitor is a potent BRAF inhibitor.

BRAF inhibitor
A3263-50 50 mg
EUR 1182
Description: BRAF inhibitor is a potent BRAF inhibitor.

CDK9 inhibitor
A3294-10 10 mg
EUR 393.6
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-100 100 mg
EUR 1796.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-5 5 mg
EUR 236.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-5.1 10 mM (in 1mL DMSO)
EUR 254.4
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

CDK9 inhibitor
A3294-50 50 mg
EUR 1015.2
Description: CDK9 inhibitor is a small-molecule selective inhibitor of CDK9 (cyclin dependent kinase 9) with IC50 value of 39 nM [1].CDKs are a group of serine/threonine kinases and are widely spread in all known eukaryotes.

PDK1 inhibitor
A3706-10 10 mg
EUR 594
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-100 100 mg
EUR 3099.6
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-5 5 mg
EUR 348
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

PDK1 inhibitor
A3706-50 50 mg
EUR 2067.6
Description: PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251µM and CHEMBL1172241 with IC50 value of 0.085µM.

NFAT Inhibitor
A4539-1 1 mg
EUR 165.6
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

NFAT Inhibitor
A4539-10 10 mg
EUR 915.6
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

NFAT Inhibitor
A4539-5 5 mg
EUR 540
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

CDK4 inhibitor
B1233-10 10 mg
EUR 562.8
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-100 100 mg
EUR 1910.4
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-25 25 mg
EUR 787.2
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-5 5 mg
EUR 390
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

CDK4 inhibitor
B1233-50 50 mg
EUR 1249.2
Description: CDK4 inhibitor is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM [1].Cyclin-dependent kinase 4 (CDK4) is a Ser/Thr protein kinase and is a member of the cyclin-dependent kinase family.

PI3K-? Inhibitor
B1869-25 each
EUR 810

PI3K-? Inhibitor
B1869-5 each
EUR 248.4

PKM2 Inhibitor
B2593-25 each
EUR 757.2

PKM2 Inhibitor
B2593-5 each
EUR 235.2

EGFR Inhibitor
C3327-1 1 mg
EUR 184.8
Description: EGFR inhibitor is a cell permeable, pyrimidine compound that selectively inhibits the EGFR kinase with IC50 value of 21 nM [1]. EGFR is a transmembrane protein, and is a receptor for members of epidermal growth factor family.

A-1155463 (BCL-XL Inhibitor)